A genetic defect in mice that impairs missing self recognition despite evidence for normal maturation and MHC class I-dependent education of NK cells

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1577-1586

  Wickström, Stina L ^a   Öberg, Linda ^a   Kärre, Klas ^a   Johansson, Maria H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL RECEPTOR NKG2D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CD1 GENE; CELL MATURATION; CHIMERA; CONTROLLED STUDY; ERYTHROCYTE; GENE LOCUS; GENETIC DISORDER; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SPLEEN CELL; TUMOR REJECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD1D; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; SELF TOLERANCE;

EID: 84896698546     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300960     Document Type: Article

References (64)

1. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
2. Vidal, S. M., S. I. Khakoo, and C. A. Biron. 2011. Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr. Opin. Virol. 1: 497-512.
3. Becknell, B., and M. A. Caligiuri. 2008. Natural killer cells in innate immunity and cancer. J. Immunother. 31: 685-692.
4. Nguyen, S., V. Béziat, D. Roos-Weil, and V. Vieillard. 2011. Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality? J. Innate Immun. 3: 383-394.
5. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
6. McQueen, K. L., and P. Parham. 2002. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14: 615-621.
7. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
8. Veillette, A. 2010. SLAM-Family Receptors: Immune Regulators with or without SAP-Family Adaptors. Cold Spring Harbor Perspect. Biol. 2: a002469.
9. Ljunggren, H.-G., and K. Kärre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11: 237-244.
10. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
11. Bix, M., N.-S. Liao, M. Zijlstra, J. Loring, R. Jaenisch, and D. Raulet. 1991. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349: 329-331.
12. Ohlén, C., P. Höglund, C. L. Sentman, E. Carbone, H.-G. Ljunggren, B. Koller, and K. Kärre. 1995. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Eur. J. Immunol. 25: 1286-1291.
13. Brodin, P., T. Lakshmikanth, K. Kärre, and P. Höglund. 2012. Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets. J. Immunol. 188: 2218-2226.
14. Johansson, S., M. Salmon-Divon, M. H. Johansson, Y. Pickman, P. Brodin, K. Kärre, R. Mehr, and P. Höglund. 2009. Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS ONE 4: e6046.
15. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
16. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y.-J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
17. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
18. Chen, Y. H., N. M. Chiu, M. Mandal, N. Wang, and C. R. Wang. 1997. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6: 459-467.
19. Hong, S., D. C. Scherer, N. Singh, S. K. Mendiratta, I. Serizawa, Y. Koezuka, and L. Van Kaer. 1999. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol. Rev. 169: 31-44.
20. Chang, C. S., L. Brossay, M. Kronenberg, and K. P. Kane. 1999. The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis. J. Exp. Med. 189: 483-491.
21. Huang, M. M., P. Borszcz, S. Sidobre, M. Kronenberg, and K. P. Kane. 2004. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1. J. Immunol. 172: 5304-5312.
22. Koller, B. H., P. Marrack, J. W. Kappler, and O. Smithies. 1990. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 248: 1227-1230.
23. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
24. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
25. Öberg, L., S. Johansson, J. Michaëlsson, E. Tomasello, E. Vivier, K. Kärre, and P. Höglund. 2004. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Eur. J. Immunol. 34: 1646-1653.
26. Tomayko, M. M., and C. P. Reynolds. 1989. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24: 148-154.
27. Brennan, J., S. Lemieux, J. D. Freeman, D. L. Mager, and F. Takei. 1996. Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J. Exp. Med. 184: 2085-2090.
28. Gosselin, P., Y. Lusignan, J. Brennan, F. Takei, and S. Lemieux. 1997. The NK2.1 receptor is encoded by Ly-49C and its expression is regulated by MHC class I alleles. Int. Immunol. 9: 533-540.
29. van Hall, T., J. van Bergen, P. A. van Veelen, M. Kraakman, L. C. Heukamp, F. Koning, C. J. Melief, F. Ossendorp, and R. Offringa. 2000. Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin. J. Immunol. 165: 869-877.
30. Gays, F., M. Unnikrishnan, S. Shrestha, K. P. Fraser, A. R. Brown, C. M. Tristram, Z. M. Chrzanowska-Lightowlers, and C. G. Brooks. 2000. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin. J. Immunol. 164: 5094-5102.
31. Franksson, L., E. George, S. Powis, G. Butcher, J. Howard, and K. Kärre. 1993. Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene. J. Exp. Med. 177: 201-205.
32. Cikes, M., S. Friberg, Jr., and G. Klein. 1973. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J. Natl. Cancer Inst. 50: 347-362.
33. Cerwenka, A., J. L. Baron, and L. L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98: 11521-11526.
34. Vahlne, G., K. Lindholm, A. Meier, S. Wickström, T. Lakshmikanth, F. Brennan, M. Wilken, R. Nielsen, F. Romagné, N. R. Wagtmann, et al. 2010. In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2. Eur. J. Immunol. 40: 813-823.
35. Vahlne, G., S. Becker, P. Brodin, and M. H. Johansson. 2008. IFN-γ production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand. J. Immunol. 67: 1-11.
36. Höglund, P., C. Ohlén, E. Carbone, L. Franksson, H. G. Ljunggren, A. Latour, B. Koller, and K. Kärre. 1991. Recognition of beta 22microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m2 mice: nonresponsiveness controlled by beta 2m-bone marrow in chimeric mice. Proc. Natl. Acad. Sci. USA 88: 10332-10336.
37. Liao, N. S., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253: 199-202.
38. Kumar, R. A., K. L. Chan, A. H. W. Wong, K. Q. Little, E. Rajcan-Separovic, B. S. Abrahams, and E. M. Simpson. 2004. Unexpected embryonic stem (ES) cell mutations represent a concern in gene targeting: lessons from "fierce" mice. Genesis 38: 51-57.
39. Taylor, M. A., B. Ward, J. D. Schatzle, and M. Bennett. 2002. Perforin- and Fasdependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur. J. Immunol. 32: 793-799.
40. Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer. 2009. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
41. Hayakawa, Y., N. D. Huntington, S. L. Nutt, and M. J. Smyth. 2006. Functional subsets of mouse natural killer cells. Immunol. Rev. 214: 47-55.
42. Hayakawa, Y., S. V. Watt, K. Takeda, and M. J. Smyth. 2008. Distinct receptor repertoire formation in mouse NK cell subsets regulated by MHC class I expression. J. Leukoc. Biol. 83: 106-111.
43. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
44. Held, W., D. Cado, and D. H. Raulet. 1996. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J. Exp. Med. 184: 2037-2041.
45. Guia, S., B. N. Jaeger, S. Piatek, S. Mailfert, T. Trombik, A. Fenis, N. Chevrier, T. Walzer, Y. M. Kerdiles, D. Marguet, et al. 2011. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci. Signal. 4: ra21.
46. Salcedo, M., M. Andersson, S. Lemieux, L. Van Kaer, B. J. Chambers, and H.- G. Ljunggren. 1998. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur. J. Immunol. 28: 1315-1321.
47. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1: 119-126.
48. Enoksson, S. L., E. K. Grasset, T. Hägglöf, N. Mattsson, Y. Kaiser, S. Gabrielsson, T. L. McGaha, A. Scheynius, and M. C. I. Karlsson. 2011. The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells. Proc. Natl. Acad. Sci. USA 108: E1399-E1407.
49. Johansson, M. H., M. A. Taylor, M. Jagodic, K. Tus, J. D. Schatzle, E. K. Wakeland, and M. Bennett. 2006. Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice. J. Immunol. 177: 7923-7929.
50. McVicar, D. W., R. Winkler-Pickett, L. S. Taylor, A. Makrigiannis, M. Bennett, S. K. Anderson, and J. R. Ortaldo. 2002. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J. Immunol. 169: 1721-1728.
51. Makrigiannis, A. P., D. Patel, M. L. Goulet, K. Dewar, and S. K. Anderson. 2005. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun. 6: 71-83.
52. Oppenheim, D. E., S. J. Roberts, S. L. Clarke, R. Filler, J. M. Lewis, R. E. Tigelaar, M. Girardi, and A. C. Hayday. 2005. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 6: 928-937.
53. Narni-Mancinelli, E., B. N. Jaeger, C. Bernat, A. Fenis, S. Kung, A. De Gassart, S. Mahmood, M. Gut, S. C. Heath, J. Estellé, et al. 2012. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 335: 344-348.
54. Zafirova, B., S. Mandarić, R. Antulov, A. Krmpotić, H. Jonsson, W. M. Yokoyama, S. Jonjić, and B. Polić. 2009. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31: 270-282.
55. Tomasello, E., P.-O. Desmoulins, K. Chemin, S. Guia, H. Cremer, J. Ortaldo, P. Love, D. Kaiserlian, and E. Vivier. 2000. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13: 355-364.
56. Cella, M., K. Fujikawa, I. Tassi, S. Kim, K. Latinis, S. Nishi, W. Yokoyama, M. Colonna, and W. Swat. 2004. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200: 817-823.
57. Colucci, F., E. Rosmaraki, S. Bregenholt, S. I. Samson, V. Di Bartolo, M. Turner, L. Vanes, V. Tybulewicz, and J. P. Di Santo. 2001. Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. J. Exp. Med. 193: 1413-1424.
58. Chan, G., T. Hanke, and K.-D. Fischer. 2001. Vav-1 regulates NK T cell development and NK cell cytotoxicity. Eur. J. Immunol. 31: 2403-2410.
59. Fujikawa, K., A. V. Miletic, F. W. Alt, R. Faccio, T. Brown, J. Hoog, J. Fredericks, S. Nishi, S. Mildiner, S. L. Moores, et al. 2003. Vav1/2/3-nullmice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement inMAPK signaling in Tand B cells. J. Exp. Med. 198: 1595-1608.
60. Lowin-Kropf, B., B. Kunz, P. Schneider, and W. Held. 2002. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur. J. Immunol. 32: 773-782.
61. Jaeger, B. N., J. Donadieu, C. Cognet, C. Bernat, D. Ordoñez-Rueda, V. Barlogis, N. Mahlaoui, A. Fenis, E. Narni-Mancinelli, B. Beaupain, et al. 2012. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J. Exp. Med. 209: 565-580.
62. Bélanger, S., M. M. Tu, M. M. Rahim, A. B. Mahmoud, R. Patel, L.-H. Tai, A. D. Troke, B. T. Wilhelm, J.-R. Landry, Q. Zhu, et al. 2012. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood 120: 592-602.
63. Dong, Z., D. Davidson, L. A. Pérez-Quintero, T. Kurosaki, W. Swat, and A. Veillette. 2012. The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells. Immunity 36: 974-985.
64. Cashman, S., K. Lampe, R. Sheridan, and K. Hoebe. 2012. An ENU mutagenesis approach to dissect "self"-induced immune responses: Unraveling the genetic footprint of immunosurveillance. OncoImmunology 1: 856-862.